Olympus Triples Venture Capital Fund Funding to Enhance MedTech Leadership
TOKYO and WESTBOROUGH, Mass., Dec 15, 2025 – (JCN Newswire) – Olympus Corporation (Olympus), a world MedTech firm committed to rising people’s lives more healthy, safer, and more gratifying, has announced a extra commitment to its corporate challenge capital fund, Olympus Innovation Ventures, LLC (OIV), with the originate of Olympus Innovation Ventures Fund II. Building on the success of the preliminary fund, Olympus will deploy $150 million to make investments in promising MedTech startup corporations enthusiastic on Gastrointestinal (GI), Urology and Respiratory.
(photo courtesy of MedTech Innovator)
OIV, a completely owned subsidiary of Olympus Corporation of the Americas, goals to generate a strong pipeline of M&A alternatives, partnerships, and precious market insights. OIV is stage-agnostic, prioritizing early to boost-stage corporations globally with therapeutic ideas for focused clinical specialties. As effectively as to capital, Olympus will proceed to lend a hand its portfolio corporations be triumphant by contributing its clinical and technical skills, glean entry to to healthcare professionals and hospitals, and talent to originate and scale modern ideas in the realm market.
OIV specializes in investments in passionate founders who’re revolutionizing clinical ideas. The fund invests in customer-driven ideas in clinical devices, diagnostics and digital health. Since its inception in October 2021, OIV has made 9 investments in areas equivalent to AI workflow ideas and clinical imaging brokers for most cancers detection.
Bob White, Director, Representative Government Officer, President and Chief Government Officer at Olympus, stated, “Our expanded challenge fund commitment reflects Olympus’ deep dedication to innovation and boost. By supporting visionary innovators and leap forward technologies over time, we scheme to droop up ideas that toughen patient outcomes and toughen our management in MedTech.”
Cerity Companions Ventures (Cerity), a firm specializing in corporate challenge capital, will proceed to lend a hand organize the Olympus challenge fund. Cerity will work carefully with senior executives of Olympus in all aspects of working the fund.
“The Cerity Companions Ventures team is excited to proceed working with Olympus, leveraging our collective technical strengths, alternate relationships, and discipline discipline subject skills to fund and toughen leading entrepreneurs,” notorious Kindra Tatarsky, Accomplice at Cerity Companions Ventures. “This fund will form on Olympus Innovation Ventures’ mission to be the accomplice of want for innovators, rising a aggressive profit for his or her startups.”
Gabriela Kaynor, Government Officer and Chief Strategy Officer at Olympus and Chair of the OIV Funding Committee, stated, “With a extra commitment to corporate challenge capital, we can proceed to glean investments in startup groups who’re building outlandish ideas in endoscopy-enabled care. Olympus Innovation Ventures investments lend a hand droop up our growth toward setting up the endosuite of the long bustle with capabilities for early detection, prognosis, and developed therapies powered by AI, robotics, and beyond.”
Olympus remains committed to strengthening its market management thru innovation, strategic partnerships, and investment in leap forward technologies. Bright forward, OIV will proceed to toughen Olympus’ commitment to elevating outlandish capabilities and power boost in the realm MedTech ecosystem.
For more records, please search recommendation from: olympusamerica.com/olympus-innovation-ventures or electronic mail: ventures@olympus.com.
About Cerity Companions Ventures
Cerity Companions Ventures partners with corporations to lend a hand originate and organize their challenge capital programs. CPV works carefully with each corporation to realize the financial and strategic benefits from challenge capital investments. The firm is a Registered Funding Adviser and maintains offices in Los Angeles, Philadelphia, and San Francisco. More records on CPV also will most definitely be stumbled on at https://ceritypartners.com/corporations/corporate-challenge-capital/
About Olympus
At Olympus, we’re committed to Our Motive of setting up people’s lives more healthy, safer and more gratifying. As a world clinical technology firm, we accomplice with healthcare professionals to provide modern ideas and companies for early detection, prognosis and minimally invasive medicine, aiming to toughen patient outcomes by elevating the customary of care in focused illness states. For more than 100 years, Olympus has pursued a operate of contributing to society by producing merchandise designed with the operate of turning in optimum outcomes for its potentialities across the sector. For more records, search recommendation from https://www.olympus-world.com/ and apply our world LinkedIn accounts.
Media contact:
Mail: Worldwide-Public_Relations@olympus.com
Olympus Corp [TYO: 7733] [ADR: OLYMY] [STU: OLY1] [FRA: OLYS] https://www.olympus-world.com
Topic: Press originate summary
Source: Olympus
Sectors: Day-to-day Finance, Healthcare & Pharm, PE, VC & Attainable picks, MedTech, Startups
http://www.acnnewswire.com
From the Asia Company News Community
Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Company News Community.
